The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL (metoprolol succinate) Extended-release Tablets (metoprolol CR/XL) in Hypertensive Pediatric Subjects: A Multicenter, Open-Label Extension of Protocol 307A.
- collapse Reversal of Ventricular Remodeling With Toprol-XL
- collapse A 16-Week Randomized, Double-blind, Parallel-group, Multicenter, Placebo- and Active- (Metformin) Controlled Study to Evaluate the Effect on Whole Body Insulin Sensitivity of Tesaglitazar Therapy when Administered to Patients with Type 2 Diabetes
- collapse An Open-Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 0.5mg When Added to Insulin Therapy in Patients with Type 2 Diabetes Mellitus (GALLEX 9)
- collapse The EXTEND Study: A Randomized, Double-Blind, Parallel-Group, Phase III b, Multi-Centre Study Evaluating Extended Prophylactic Treatment With Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events in Patients Undergoing Elective Hip Replacement or Hip Fracture Surgery.
- collapse Study to Assess the Metabolism, Excretion and Pharmacokinetics of [14C]AZD1981 in Healthy Male Volunteers
- collapse A 4-Week Dose-Ranging Study to Evaluate Antidyslipidemic Effects, Other Pharmacodynamic Effects, Safety, and Tolerability of AZD6610 with Concomitant Open-Label Simvastatin Therapy in Patients with Elevated Triglycerides, Elevated Low Density Lipid Cholesterol and Abdominal Obesity: a Randomized, Double-Blind, Placebo-Controlled, Multi-Centre, Parallel-Group Study with Fenofibrate as Reference
- collapse A randomised, single-blind, placebo-controlled, single-centre phase I study in healthy Japanese male volunteers to assess the safety, tolerability and pharmacokinetics of AZD4017 after single ascending oral doses
- collapse A randomised, single-blind, placebo-controlled, single centre, Phase I study in healthy volunteers to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4017 after repeated ascending oral doses
- collapse A Randomized, Single-blind, Placebo-controlled, Single-centre, Phase 1
